We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.62B
AUM Growth
-$84.4M
Cap. Flow
-$358M
Cap. Flow %
-9.89%
Top 10 Hldgs %
26.83%
Holding
5,773
New
537
Increased
1,570
Reduced
3,043
Closed
580

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$46.2M
2
MSFT icon
Microsoft
MSFT
+$46.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$40M
4
NVDA icon
NVIDIA
NVDA
+$27.6M
5
PLTR icon
Palantir
PLTR
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 17.33%
2 Financials 7.48%
3 Consumer Discretionary 6.48%
4 Healthcare 6.28%
5 Communication Services 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IHS icon
5401
IHS Holding
IHS
$2.81B
-12,861
Closed -$71.5K
IJT icon
5402
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.41B
-14,944
Closed -$1.99M
IMMX icon
5403
Immix Biopharma
IMMX
$692M
-131
Closed -$271
IMRX icon
5404
Immuneering
IMRX
$292M
-2,984
Closed -$10.1K
IMTX icon
5405
Immatics
IMTX
$1.32B
-1,081
Closed -$5.82K
IMUX icon
5406
Immunic
IMUX
$195M
-201
Closed -$1.4K
INDL icon
5407
Direxion Daily MSCI India Bull 2X ETF
INDL
$58.2M
-1
Closed -$63
INM icon
5408
InMed Pharmaceuticals
INM
$7.85M
-400
Closed -$1.3K
INO icon
5409
Inovio Pharmaceuticals
INO
$69M
-11,687
Closed -$23.8K
INTG icon
5410
InterGroup Corp
INTG
$67.4M
-540
Closed -$6.24K
INTZ
5411
Intrusion
INTZ
$17.3M
-2,708
Closed -$6.2K
INUV icon
5412
Inuvo
INUV
$17M
-200
Closed -$920
INZY
5413
DELISTED
Inozyme Pharma
INZY
-12,849
Closed -$51.4K
IOO icon
5414
iShares Global 100 ETF
IOO
$9.5B
-5
Closed -$539
ISPY icon
5415
ProShares S&P 500 High Income ETF
ISPY
$1.27B
-1
Closed -$42
ITM icon
5416
VanEck Intermediate Muni ETF
ITM
$2.13B
-9
Closed -$409
ITOS
5417
DELISTED
iTeos Therapeutics
ITOS
-3,953
Closed -$39.4K
IUSB icon
5418
iShares Core Universal USD Bond ETF
IUSB
$43.3B
-55
Closed -$2.54K
IWC icon
5419
iShares Micro-Cap ETF
IWC
$1.5B
-2
Closed -$255
IWV icon
5420
iShares Russell 3000 ETF
IWV
$20.4B
-20,082
Closed -$7.05M
IXG icon
5421
iShares Global Financials ETF
IXG
$700M
-1
Closed -$111
IXJ icon
5422
iShares Global Healthcare ETF
IXJ
$4.19B
-1
Closed -$86
IYJ icon
5423
iShares US Industrials ETF
IYJ
$1.95B
-144
Closed -$20.5K
IYZ icon
5424
iShares US Telecommunications ETF
IYZ
$1.23B
-907
Closed -$27K
IZM icon
5425
ICZOOM Group
IZM
$3.04M
-497
Closed -$1.35K

Similar funds

Tower Research Capital (TRC)'s Q3 2025 Portfolio in Review

As of Q3 2025, Tower Research Capital (TRC) held 5,773 positions worth $3.62B, down 2.3% from $3.71B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) withdrew a net $358M in Q3 2025, closing 580 positions and reducing 3,043 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $23.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in JPMorgan Ultra-Short Income ETF worth $30.6M.

  • Tower Research Capital (TRC)'s largest Q3 2025 buy was JPMorgan Ultra-Short Income ETF: 603,010 shares worth $30.6M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $254M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2025 reduction was Apple, cutting an estimated $46.2M.
  • Tower Research Capital (TRC) fully exited Vanguard S&P 500 ETF in Q3 2025, selling an estimated $23.6M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $3.62B portfolio in Q3 2025.
  • Tower Research Capital (TRC) opened 537 new positions and closed 580 in Q3 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 2.3% quarter-over-quarter to $3.62B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.